The Food and Drug Administration on Friday said the shortage of Novo Nordisk's weight-loss and diabetes drugs Wegovy and Ozempic is resolved, a move that could limit the availability of cheaper ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now. By Rebecca Robbins It’s easy to make a medical case for ...

Wegovy (semaglutide) is a brand-name drug prescribed for weight management and to lower the risk of cardiovascular problems. Wegovy comes as a solution in single-use injection pens. It’s ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday. The update about the popular semaglutide injections ...

The U.S. Food and Drug Administration declared that the shortage of Novo Nordisk’s NOVO.B0.81%increase; green up pointing triangle weight-loss medications Wegovy and Ozempic has been resolved ...

You may have done your research and settled on Wegovy for weight management or cardiovascular health. Now what? Telemedicine options might be your ticket to fulfill the prescription, deliver it ...

Wegovy (semaglutide) is a brand-name subcutaneous injection pen. It’s prescribed for weight loss and to lower cardiovascular risks. Wegovy interacts with some other drugs and certain supplements ...

Feb 21 (Reuters) - The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's NOVOb.CO popular weight-loss and diabetes drugs, Wegovy and Ozempic ...

The Food and Drug Administration announced Friday it had officially declared an end to the nationwide shortage of Ozempic and Wegovy, medications used for diabetes and weight loss. The agency ...